Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device
Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore™ Device, for the Relief of Acute Bronchoconstriction Due to Asthma
Sponsor: ElectroCore INC
This NA trial investigates Asthma and is currently completed. ElectroCore INC leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
Phase: PHASE2 → NA
-
Feb 2018 — May 2018 [monthly]
Completed PHASE2
-
Feb 2017 — Feb 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ElectroCore INC
For direct contact, visit the study record on ClinicalTrials.gov .